Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: A 10-year study

Vaccine

Volumn 30, Issue SUPPL. 6, 2012, Pages

  Charfi, F ^a   Smaoui, H ^a   Kechrid, A ^a  

^a CHILDREN S HOSPITAL   (Tunisia)

Author keywords

Antibiotic; Conjugate vaccine; Serotype; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; KANAMYCIN; OXACILLIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; PRISTINAMYCIN; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ANTIGEN ANTIBODY REACTION; BACTERIUM ISOLATION; CHILD; CHILDHOOD DISEASE; DISK DIFFUSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TUNISIA;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TUNISIA;

EID: 84870830594     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.017     Document Type: Review

References (32)

1. García-Suárez M., Villaverde R., Caldevilla A.F., Méndez F.J., Vázquez F. Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumococcal isolates in Asturias, Spain. Jpn J Infect Dis 2006, 59:299-305.
2. Thabet F., Tilouche S., Tabarki B., Amri F., Guediche M.N., Sfar M.T., et al. Mortalité par méningites à pneumocoque chez l'enfant. Facteurs pronostiques à propos d'une série de 73 observations. Arch Pediatr 2007, 14:334-337. [article in French].
3. Felmingham D., Reinert R.R., Hirakata Y., Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 2002, 50(Suppl. S1):25-37.
4. Smaoui H., Amri J., Hajji N., Kechrid A. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolates in children in Tunis. Arch Pediatr 2009, 16(3):220-226. [article in French].
5. Hausdorff W.P., Bryant J., Paradiso P.R., Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000, 30:100-121.
6. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction protein-polysaccharide conjugate vaccine. N Engl J Med 2003, 348:1737-1746.
7. Centers for Disease Control and Prevention Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007. MMWR 2010, 59(9):253-257.
8. Soussy CJ. Comité de l'Antibiogramme de la Société Française de Microbiologie. Recommandations; 2009.
9. World Health Organization Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly Epidemiol Rec 2007, 82:93-104.
10. Cho H.K., Lee H., Kang J.H., Kim K.N., Kim D.S., Kim Y.K., et al. The causative organisms of bacterial meningitis in Korean children in 1996-2005. J Korean Med Sci 2010, 25:895-899.
11. Thabet L., Boussetta K., Kaabachi O., Smaoui H., Kechrid A. Profil bactériologique des méningites purulentes à l'Hôpital d'Enfants de Tunis. Méd Mal Infect 2002, 32:1-7.
12. Levy C., De La Rocque F., Cohen R. Actualisation de l'épidémiologie des méningites bactériennes de l'enfant en France. Méd Mal Infect 2009, 39:419-431. [article in French].
13. Feki-Berrajah L., Mahjoubi-Rhimi F., Karray-Hakim H., Ben Salah-Maaloul F., Kallel C., Hammami A. Streptococcus pneumoniae of lesser sensitivity to penicillin in the Sfax region, Tunisia (1994-1995). Pathol Biol (Paris) 1998, 46(5):331-334.
14. Reinert R.R. The antimicrobial resistance profile of Streptococcus pneumoniae. Clin Microbiol Infect 2009, 15(Suppl. 3):7-11.
15. Benbachir M., Benredjeb S., Boye C.S., Dosso M., Belabbes H., Kamoun A., et al. Two-year surveillance of antibiotic resistance in Streptococcus pneumoniae in four African cities. Antimicrob Agents Chemother 2001, 45:627-629.
16. Granizo J.J., Aguilar L., Casal J., Garcia-Rey C., Dal-ré R., Baquero F. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and β-lactam consumption in Spain (1979-1997). J Antimicrob Chemother 2000, 46:767-773.
17. Guillemot D., Varon E., Bernède C., Weber P., Henriet L., Simon S., et al. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin Infect Dis 2005, 41:930-938.
18. Varon E, Gutmann L. Rapport d'activités du Centre National de Référence des Pneumocoques; 2005.
19. Bingen E. Place du pneumococque en pathologie infectieuse pédiatrique. Path Biol 2002, 50:374-379. [article in French].
20. Dias R., Canica M. Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14. J Antimicrob Chemother 2004, 54:1035-1039.
21. Montagnani F., Fanetti A., Stolzuoli L., Croci L., Arena F., Zanchi A., et al. Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and micribiological case series from 1992 to 2006. J Infect 2008, 56:179-184.
22. Smaoui H., Saguer A., Kechrid A. Study of the sensitivity to antibiotics and genes for macrolide resistance to Streptococcus pneumoniae isolated in a pediatric Tunisian setting. Revue Tunisienne d'Infectiologie 2011, 5(2):87-92.
23. Rachdi M., Boutiba-Ben Boubaker I., Moalla S., Smaoui H., Hammami A., Kechrid A., et al. Phenotypic and genotypic characterization of macrolide resistant S. pneumoniae in Tunisia. Pathol Biol (Paris) 2008, 56:125-129.
24. Riedel S., Beekmann S.E., Heilmann K.P., Richter S.S., Garcia-de-Lomas J., Ferech M., et al. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2007, 26(7):485-490.
25. Isaacman D.J., Mcintosh E.D., Reinert R.R. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 2010, 14(3):e197-e209.
26. Imöhl M., Reinert R.R., van der Linden M. New penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effects on susceptibility categorisation in Germany (1992-2008). Int J Antimicrob Agents 2009, 34:271-273.
27. Shibl A.M. Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5years and under in Saudi Arabia (2000-2004). Clin Microbiol Infect 2008, 14(9):876-879.
28. Harboe Z.B., Thomsen R.W., Riis A., Valentiner-Branth P., Christensen J.J., Lambertsen L., et al. Peumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009, 6(5):e10000081.
29. Xu X., Cai L., Xiao M., Kong F., Oftadeh S., Zhou F., et al. Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates. Antimicrob Agents Chemother 2010, 54(3):1152-1159.
30. Pavia M., Bianco A., Nobile C.G., Marinelli P., Angellilo I.F. Efficacy of pneumococcal vaccination in children younger than 24months: a meta-analysis. Pediatrics 2009, 23(6):e1103-e1110.
31. Hanquet G., Kissling E., Fenoll A., George R., Lepoutre A., Lernout T., et al. Pneumococcal serotypes in children in 4 European countries. Emerg Infect Dis 2010, 16(9):1428-1439.
32. Hausdorff W.P., Bryant J., Kloek C., Paradiso P.R., Siber G.R. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 2000, 30:122-140.